IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.587
AS - Asia 1.492
EU - Europa 669
SA - Sud America 448
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 44
OC - Oceania 4
Totale 4.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.513
SG - Singapore 614
BR - Brasile 366
CN - Cina 315
IT - Italia 157
VN - Vietnam 153
HK - Hong Kong 149
DE - Germania 134
BD - Bangladesh 82
RU - Federazione Russa 68
GB - Regno Unito 64
FR - Francia 62
TR - Turchia 55
CA - Canada 38
IN - India 33
CZ - Repubblica Ceca 32
AR - Argentina 28
UA - Ucraina 27
AT - Austria 26
FI - Finlandia 23
MX - Messico 18
NL - Olanda 18
EC - Ecuador 17
JP - Giappone 16
ZA - Sudafrica 14
ID - Indonesia 13
PL - Polonia 13
SE - Svezia 12
IQ - Iraq 9
CO - Colombia 8
PY - Paraguay 8
CL - Cile 7
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 7
BE - Belgio 6
KE - Kenya 6
UZ - Uzbekistan 6
JM - Giamaica 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
HN - Honduras 4
TW - Taiwan 4
AZ - Azerbaigian 3
DZ - Algeria 3
HU - Ungheria 3
IL - Israele 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
Totale 4.244
Salva come PNG Salva come JPEG
Città #
Singapore 299
San Jose 164
Ashburn 159
Hong Kong 149
The Dalles 119
Council Bluffs 76
Beijing 66
Los Angeles 59
New York 54
Ho Chi Minh City 53
Lauterbourg 49
Dallas 48
Columbus 47
Istanbul 47
Munich 40
Hanoi 38
Santa Clara 38
Boardman 35
Fairfield 32
Nuremberg 32
Des Moines 31
Moscow 28
São Paulo 28
Buffalo 27
Houston 24
Romola 24
Chicago 22
San Francisco 21
Woodbridge 21
Redondo Beach 19
Milan 17
Olomouc 17
Shanghai 17
Orem 16
Turku 16
Brno 15
Denver 15
Mumbai 14
Rio de Janeiro 14
Seattle 14
Tokyo 14
London 13
Manchester 13
Vienna 13
Frankfurt am Main 12
Montreal 12
Stockholm 12
Atlanta 11
Brooklyn 11
Warsaw 11
Boston 10
Charlotte 10
Jacksonville 10
Wilmington 10
Curitiba 9
Phoenix 9
Rome 9
Toronto 9
Belo Horizonte 8
Cambridge 8
Mexico City 8
Poplar 8
Ribeirão Preto 8
Amsterdam 7
Chandler 7
Düsseldorf 7
Helsinki 7
Naples 7
Philadelphia 7
Porto Alegre 7
Chennai 6
Hải Dương 6
Nairobi 6
Tashkent 6
Amman 5
Brussels 5
Buenos Aires 5
Cape Town 5
Dearborn 5
Florence 5
Goiânia 5
Guayaquil 5
Jinan 5
Johannesburg 5
Kingston 5
Kunming 5
New Delhi 5
Ottawa 5
Padova 5
Princeton 5
Quito 5
São José dos Campos 5
Biên Hòa 4
Brasília 4
Cotia 4
Da Nang 4
Dhaka 4
Imperatriz 4
Ipatinga 4
Nanjing 4
Totale 2.437
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 224
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 201
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 104
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 104
Applying the ATN scheme in a memory clinic population: The ABIDE project 102
Clinical utility of FDG-PET for the clinical diagnosis in MCI 97
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 96
AMYPAD Diagnostic and Patient Management Study: Rationale and design 95
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 94
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 93
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 93
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 93
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 93
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 92
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 92
Brain atrophy in Alzheimer's Disease and aging 90
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 90
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 86
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 85
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 85
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 84
Medial temporal lobe atrophy and posterior atrophy scales normative values 84
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 83
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 80
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 79
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 78
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 78
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 78
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 78
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 76
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 76
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 76
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 75
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 74
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 71
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 70
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 69
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 69
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 69
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 68
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 66
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 66
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 65
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 60
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 57
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 53
Multitracer model for staging cortical amyloid deposition using PET imaging 52
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 49
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 48
Feasibility of a standard cognitive assessment in European academic memory clinics 46
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology 46
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 41
The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection 27
Totale 4.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/20251.152 31 1 57 148 76 79 137 17 189 84 195 138
2025/20262.498 221 367 201 362 234 149 326 68 147 190 141 92
2026/2027192 113 79 0 0 0 0 0 0 0 0 0 0
Totale 4.300